Javad Ranjbaran
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Javad Ranjbaran has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Elham Chamani
Department of Clinical Biochemistry, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran - Geriatric Health Research Center, Birjand University of Medical Sciences, Birjand, Iran
2 shared publications - Hossein Safarpour
Cellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, Iran
2 shared publications - Tahmine Tavakoli
Geriatric Health Research Center, Birjand University of Medical Sciences, Birjand, Iran
2 shared publications - Ali Dashtgard
Department of Nursing, Qaen Faculty of Medical Sciences, Birjand University of Medical Sciences, Birjand, Iran
1 shared publication - Fatemeh Salmani
Department of Epidemiology and Biostatistics, School of Health, Social Determinants of Health Research Center, Birjand University of Medical Sciences, Birjand, Iran
1 shared publication - Fatemeh Salmani
Geriatric Health Research Center, Birjand University of Medical Sciences, Birjand, Iran - Department of Epidemiology and Biostatistics, Social Determinants of Health Research Center, Faculty of Health, Birjand University of Medical Sciences, Birjand, Iran
1 shared publication
Latest Publications
- Open Access
- 29 May 2025
- Published by Farname, Inc. in Journal of Advances in Medical and Biomedical Research
- Vol. 33 (157) , 96-104
Exploring the Diagnostic Potential of hsa-circRNA-001587 and hsa-circ-0004872 in Colorectal Cancer: A Population-Based Diagnostic Approach
Background & Objective: Colorectal cancer contributes substantially to global cancer mortality, ranking among the leading causes of cancer-related deaths. Studies have linked its development to diminished expression of the SLC4A4 gene alongside elevated levels of the microRNAs hsa-miR-223-3p and hsa-miR-106a-5p. This study examines hsa-circRNA-001587 and hsa-circ-0004872 to determine their utility ...
- 29 May 2025
- Published by Farname, Inc. in Journal of Advances in Medical and Biomedical Research
- Vol. 33 (157) , 96-104
Open AccessExploring the Diagnostic Potential of hsa-circRNA-001587 and hsa-circ-0004872 in Colorectal Cancer: A Population-Based Diagnostic Approach
Background & Objective: Colorectal cancer contributes substantially to global cancer mortality, ranking among the leading causes of cancer-related deaths. Studies have linked its development to diminished expression of the SLC4A4 gene alongside elevated levels of the microRNAs hsa-miR-223-3p and hsa-miR-106a-5p. This study examines hsa-circRNA-001587 and hsa-circ-0004872 to determine their utility ...
- Open Access
- 15 May 2024
- Published by Elsevier in New Microbes and New Infections
- Vol. 60-61, 101432
Investigating the effects of the Omicron variant of COVID-19 on sperm parameters and serum levels of male sexual hormones: Prospective observational study
- 15 May 2024
- Published by Elsevier in New Microbes and New Infections
- Vol. 60-61, 101432
Open AccessInvestigating the effects of the Omicron variant of COVID-19 on sperm parameters and serum levels of male sexual hormones: Prospective observational study
- Open Access
- 5 December 2022
- Published by Wiley in Cancer Medicine
- Vol. 12 (6) , 7005-7018
Experimental validation of in silico analysis estimated the reverse effect of upregulated hsa‐miR‐106a‐5p and hsa‐miR‐223‐3p on SLC4A4 gene expression in Iranian patients with colorectal adenocarcinoma by RT‐qPCR
Background and Methods: Colorectal cancer (CRC) is considered one of the most common malignancies worldwide. The diagnosis and prognosis of the patients are very poor. In this study, we used in‐silico analysis and experimental techniques to investigate novel co‐expression genes and their associated miRNA networks in CRC. For this purpose, we conducted a comprehensive transcriptome analysis using online bulk and single‐cell RNA‐seq datasets. We then validated the results on tissue samples from cancerous and adjacent normal tissues from CRC patients by RT‐qPCR.Results: Using a weighted gene co‐expression network algorithm, we identified SLC4A4 as a significantly downregulated hub gene in the CRC. The single‐cell analysis indicated that the expression level of SLC4A4 in Paneth cells is higher than in other cell populations. Further computational analysis suggested hsa‐miR‐223‐3p and hsa‐miR‐106a‐5p as two specific hub‐miRNAs for the SLC4A4 gene. RT‐qPCR analysis showed a 2.60‐fold downregulation of SLC4A4. Moreover, hsa‐miR‐223‐3p and hsa‐miR‐106a‐5p showed an increased expression level of 5.58‐fold and 9.66‐fold in CRC samples, respectively. Based on the marginal model analysis, by increasing the expression of hsa‐miR‐106a‐5p, the average expression of the SLC4A4 gene significantly decreased by 103 units. Furthermore, ROC curves analysis indicated statistically significant for diagnostic ability of SLC4A4 (AUC: 0.94, Sensitivity: 95.5%, Specificity: 95.5%) and hsa‐miR‐106a‐5p (AUC: 0.72, Sensitivity: 72.7%, Specificity: 100%).Conclusion: This study provides a framework of co‐expression gene modules and miRNAs of CRC, which identifies some important biomarkers for CRC pathogenicity and diagnosis. Further experimental evidence will be required to support this study and validate the precise molecular pathways.
- 5 December 2022
- Published by Wiley in Cancer Medicine
- Vol. 12 (6) , 7005-7018
Open AccessExperimental validation of in silico analysis estimated the reverse effect of upregulated hsa‐miR‐106a‐5p and hsa‐miR‐223‐3p on SLC4A4 gene expression in Iranian patients with colorectal adenocarcinoma by RT‐qPCR
Background and Methods: Colorectal cancer (CRC) is considered one of the most common malignancies worldwide. The diagnosis and prognosis of the patients are very poor. In this study, we used in‐silico analysis and experimental techniques to investigate novel co‐expression genes and their associated miRNA networks in CRC. For this purpose, we conducted a comprehensive transcriptome analysis using online bulk and single‐cell RNA‐seq datasets. We then validated the results on tissue samples from cancerous and adjacent normal tissues from CRC patients by RT‐qPCR.Results: Using a weighted gene co‐expression network algorithm, we identified SLC4A4 as a significantly downregulated hub gene in the CRC. The single‐cell analysis indicated that the expression level of SLC4A4 in Paneth cells is higher than in other cell populations. Further computational analysis suggested hsa‐miR‐223‐3p and hsa‐miR‐106a‐5p as two specific hub‐miRNAs for the SLC4A4 gene. RT‐qPCR analysis showed a 2.60‐fold downregulation of SLC4A4. Moreover, hsa‐miR‐223‐3p and hsa‐miR‐106a‐5p showed an increased expression level of 5.58‐fold and 9.66‐fold in CRC samples, respectively. Based on the marginal model analysis, by increasing the expression of hsa‐miR‐106a‐5p, the average expression of the SLC4A4 gene significantly decreased by 103 units. Furthermore, ROC curves analysis indicated statistically significant for diagnostic ability of SLC4A4 (AUC: 0.94, Sensitivity: 95.5%, Specificity: 95.5%) and hsa‐miR‐106a‐5p (AUC: 0.72, Sensitivity: 72.7%, Specificity: 100%).Conclusion: This study provides a framework of co‐expression gene modules and miRNAs of CRC, which identifies some important biomarkers for CRC pathogenicity and diagnosis. Further experimental evidence will be required to support this study and validate the precise molecular pathways.